AstraZeneca (AZN) Earnings
|
Expand Research on AZN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +85.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/29/22 | Q222 | N/A | $0.81 | N/A | N/A | $10.61B | N/A | N/A | N/A | ||
| 4/29/22 |  |
Q122 | $1.89 | $0.83 | +$1.06 | $11.4B | $10.99B | N/A |  | | Details |
| 2/10/22 | |
Q421 | $1.67 | $0.73 | +$0.94 | $12.01B | $10.96B | N/A | | | Details |
| 11/12/21 | |
Q321 | $1.08 | $0.62 | +$0.46 | $9.87B | $9.87B | N/A | | | Details |
7/29/21  |
|
Q221 | N/A | $0.43 | N/A | N/A | $7.36B | N/A | N/A | N/A | |
| 4/30/21 |
|
Q121 | N/A | $0.75 | N/A | N/A | $7.14B | N/A | N/A | N/A | |
| 2/11/21 |
|
Q420 | N/A | $0.68 | N/A | N/A | $6.97B | N/A | N/A | N/A | |
| 11/5/20 |
Q320 | N/A | $0.44 | N/A | N/A | $6.67B | N/A | N/A | N/A |
